Rheumatoid Arthritis

Catastrophic APS: Can You Clinch the Diagnosis?

In CAPS, the most severe form of antiphospholipid syndrome, thromboses emerge widely and rapidly--clearly an urgent situation. Update your diagnostic skills in this quick two-part quiz

Rheumatoid Arthritis

About half of rheumatoid arthritis patients don't understand enough information to make intelligent treatment choices. Here's how to help.

A new meta-analysis shows RA treatments have varied effects on patients’ response to flu and pneumonia vaccines.

With some historical analysis, a British rheumatologist unearths a persuasive explanation for the emergence of rheumatoid arthritis when and where it did, in fact, arise.

Biologics have added a decade to the lifespan of rheumatoid arthritis patients since only the start of this century. The impact of age on that treatment has been a subject of intense study.

An online survey suggests that rheumatoid arthritis (RA) patients want quicker, less frequent treatments even if the trade-offs are adverse reactions or less efficacy.

(EULAR2014) Which candidate biologics for rheumatology are destined to pass "Go" and collect? A member of the audience at the recent conference presents his observations and comments.

Comparison of inflamed and non-inflamed synovium provide support for targeting a receptor for a molecule that stimulates granulocytes in rheumatoid and psoriatic arthritis.


Subscribe to Rheumatoid Arthritis on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.